Skip Ribbon Commands
Skip to main content

Hemophilia - Treatments

All bleeding episodes have to be treated promptly by increasing the level of factor 8 or 9 as necessary. Increasing blood factors can be achieved by infusion of commercially available factor concentrates.

Preparations of factor concentrates are made with pooled donor plasma (from many blood donors) or recombinant technology (from genetic manipulation of animal cells to produce human factors). The administration of factors will be done by a medical professional or be taught to people living with haemophilia or their caregivers (ie home treatment) which decreases their dependency on hospital treatment.

The administration of foreign factor 8 or 9 may at times lead to the development of antibodies against these factors and a change in treatment regimens. Non-factor replacement products such as emicizumab are now available with limited accessibility to select group of individuals. Intensive study on gene therapy to correct the abnormal gene in haemophilia directly is currently undertaken in several major centres with the possibility of this being an additional treatment option in the near future.

The haemophilia service at SGH provides a multidisciplinary approach to care for patients living with haemophilia. 
national hemophilia registry singapore general hospital

Hemophilia - Preparing for surgery

Hemophilia - Post-surgery care

Hemophilia - Other Information

The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.